Biberach, Germany

Leo Thomas

This inventor holds 62 USPTO granted patents and 40 published patent applications, plus 11 CIPO patents and 22 EPO patents, primarily in Pharmaceutical Innovation (CPC class A61K). Top assignees: Boehringer Ingelheim International Gmbh, Zealand Pharma A/s, Ajinomoto Co., Ltd.. Active years: 1999-2026.

USPTO Granted Patents = 62 

% Patents Active = 96.8

 

 

Average Co-Inventor Count = 4.9

ph-index = 31

Forward Citations = 2,203(Granted Patents)

Forward Citations (Not Self Cited) = 1,981(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Biberach, DE (1999 - 2014)
  • Ingelheim am Rhein, DE (2015 - 2022)
  • Biberach an der Riss, DE (2015 - 2023)

Company Filing History:


Years Active: 1999-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Pharmaceutical Compositions
Diabetes Therapy
Ocular Diseases
Glucagon Analogues
Anti-VEGF
Eye Treatments
Combination Therapy
MCH Antagonists
Glucopyranosyl Derivatives
Thienopyrimidines
Platelet Activating Factor
Anti-NRP1A Antibodies
62 patents (USPTO):Explore Patents

Title: The Innovator: Leo Thomas - Pioneering Medical Treatments

Introduction: Leo Thomas, a distinguished inventor hailing from Biberach, Germany, has made significant strides in the field of medical innovations. With an impressive portfolio of 52 patents, Leo Thomas has been at the forefront of developing groundbreaking solutions for various health challenges.

Latest Patents: Among his latest patents, Leo Thomas has introduced revolutionary concepts such as "Glucagon analogues as long-acting GLP-1/glucagon receptor agonists in the treatment of fatty liver disease and steatohepatitis." This cutting-edge invention focuses on the medical application of specific long-acting glucagon analogues with dual GLP-1/glucagon receptor agonist activity for preventing and treating metabolic liver diseases. Additionally, his patent on "Cyclopentathiophene carboxamide derivatives as platelet activating factor receptor antagonists" demonstrates his commitment to developing treatments for diseases influenced by the platelet activating factor receptor.

Career Highlights: Leo Thomas has made significant contributions to the field while working at reputable companies such as Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma GmbH & Co. KG. His innovative spirit and dedication to advancing medical solutions have earned him recognition as a key figure in the pharmaceutical industry.

Collaborations: Throughout his career, Leo Thomas has collaborated with esteemed colleagues such as Frank Himmelsbach and Matthias Eckhardt. Together, they have combined their expertise to drive forward groundbreaking research and develop impactful solutions for pressing health issues.

Conclusion: In conclusion, Leo Thomas stands out as a visionary inventor who has revolutionized the medical field with his innovative patents and breakthrough discoveries. His relentless pursuit of excellence and collaborative efforts have paved the way for transformative advancements in healthcare. Leo Thomas's contributions continue to inspire and shape the future of medical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…